At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
IMCC IM Cannabis Corp
Trading 08-20 14:18:29 EDT
0.1100
+0.0040
+3.77%
High0.1121Low0.1020Vol1.08M
Open0.1028D1 Closing0.1060Amplitude9.53%
Mkt Cap1.79MTradable Cap754.26KTotal Shares16.30M
T/O116.76KT/O Rate15.80%Tradable Shares6.86M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

IM Cannabis Plans 30-for-1 Share Consolidation to Meet NASDAQ US$1 Minimum Bid Rule
Reuters  ·  08-19 05:01
IM Cannabis Plans 30-for-1 Share Consolidation to Meet NASDAQ US$1 Minimum Bid Rule
IM Cannabis Announces Intention to Complete 30:1 Share Consolidation to Support NASDAQ Minimum Bid Price Compliance
THOMSON REUTERS  ·  08-19 05:01
IM Cannabis Announces Intention to Complete 30:1 Share Consolidation to Support NASDAQ Minimum Bid Price Compliance
Top Premarket Decliners
MT Newswires Live  ·  08-17
Top Premarket Decliners
IM Cannabis Signs Deal to Sell IMC Holdings, European Assets to Slil.com Holding
Reuters  ·  08-17
IM Cannabis Signs Deal to Sell IMC Holdings, European Assets to Slil.com Holding
IM Cannabis Corp - Deal Consideration Includes C$3 Mln Advance and Assumption of Liabilities up to C$9.4 Mln
THOMSON REUTERS  ·  08-17
IM Cannabis Corp - Deal Consideration Includes C$3 Mln Advance and Assumption of Liabilities up to C$9.4 Mln
IM Cannabis Enters into Agreement to Sell Imc Holdings and European- Focused Assets
THOMSON REUTERS  ·  08-17
IM Cannabis Enters into Agreement to Sell Imc Holdings and European- Focused Assets
IM Cannabis Corp - to Retain Core Israeli Medical Cannabis Operations After Closing
THOMSON REUTERS  ·  08-17
IM Cannabis Corp - to Retain Core Israeli Medical Cannabis Operations After Closing
Canadian Biopharma Firm Avicanna's Q2 Revenue Falls on VAC Reimbursement Changes
Reuters  ·  08-15
Canadian Biopharma Firm Avicanna's Q2 Revenue Falls on VAC Reimbursement Changes
Canada's IM Cannabis Q2 Loss Widens as Revenue Drops, Finance Expenses Rise
Reuters  ·  08-14
Canada's IM Cannabis Q2 Loss Widens as Revenue Drops, Finance Expenses Rise
IM Cannabis Q2 Revenue CAD 7.589 Million
THOMSON REUTERS  ·  08-14
IM Cannabis Q2 Revenue CAD 7.589 Million
IM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial Results
THOMSON REUTERS  ·  08-14
IM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial Results
IM Cannabis FY26 H1 Net Loss Widens to C$6.9 Million; Revenue Falls 35.32% to C$16.3 Million vs FY25 H1
Reuters  ·  08-14
IM Cannabis FY26 H1 Net Loss Widens to C$6.9 Million; Revenue Falls 35.32% to C$16.3 Million vs FY25 H1
IM Cannabis Prices Us$250,000 Convertible Note Private Placement with Institutional Investor
Reuters  ·  08-08
IM Cannabis Prices Us$250,000 Convertible Note Private Placement with Institutional Investor
IM Cannabis Raises Us$250,000 of Gross Proceeds in Convertible Note Financing
THOMSON REUTERS  ·  08-08
IM Cannabis Raises Us$250,000 of Gross Proceeds in Convertible Note Financing
IM Cannabis Director Alon Dayan Resigns for Personal Reasons
Reuters  ·  07-28
IM Cannabis Director Alon Dayan Resigns for Personal Reasons
IM Cannabis Provides Corporate Update
THOMSON REUTERS  ·  07-28
IM Cannabis Provides Corporate Update
IM Cannabis Closes Convertible Note Financing
MT Newswires Live  ·  07-02
IM Cannabis Closes Convertible Note Financing
IM Cannabis Issues Warrants for 1,483,386 Shares at C$ 0.22 in Note Financing
Reuters  ·  07-02
IM Cannabis Issues Warrants for 1,483,386 Shares at C$ 0.22 in Note Financing
Press Release: IM Cannabis Raises Us$225,000 of Gross Proceeds in Convertible Note Financing
Dow Jones  ·  07-02
Press Release: IM Cannabis Raises Us$225,000 of Gross Proceeds in Convertible Note Financing
IM Cannabis enters LOI to sell European assets to Slil.com, cutting debt by CAD 10.5 million
Reuters  ·  06-18
IM Cannabis enters LOI to sell European assets to Slil.com, cutting debt by CAD 10.5 million

Introduction

Company Name.
IM Cannabis Corp
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.
Issue price:
--